Bristol-Myers Squibb Company (LON:0R1F)

London flag London · Delayed Price · Currency is GBP · Price in USD
60.30
+0.95 (1.60%)
Feb 20, 2026, 5:14 PM GMT
Market Cap91.56B -5.4%
Revenue (ttm)35.81B -0.2%
Net Income5.24B
EPS2.57
Shares Outn/a
PE Ratio17.47
Forward PE9.66
Dividend1.86 (3.09%)
Ex-Dividend DateJan 2, 2026
Volume24,497
Average Volume10,945
Open60.30
Previous Close59.35
Day's Range59.25 - 60.69
52-Week Range42.54 - 63.17
Beta0.30
RSI64.93
Earnings DateFeb 5, 2026

About LON:0R1F

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat ... [Read more]

Sector Healthcare
Founded 1887
Employees 32,500
Stock Exchange London Stock Exchange
Ticker Symbol 0R1F
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements